[go: up one dir, main page]

CN106474565A - A kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material - Google Patents

A kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material Download PDF

Info

Publication number
CN106474565A
CN106474565A CN201611126018.1A CN201611126018A CN106474565A CN 106474565 A CN106474565 A CN 106474565A CN 201611126018 A CN201611126018 A CN 201611126018A CN 106474565 A CN106474565 A CN 106474565A
Authority
CN
China
Prior art keywords
maltodextrin
silk fibroin
tussah silk
preparation
scaffold material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201611126018.1A
Other languages
Chinese (zh)
Inventor
王群
刘静
程曼
李存福
郭靖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taizhou University
Original Assignee
Taizhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taizhou University filed Critical Taizhou University
Priority to CN201611126018.1A priority Critical patent/CN106474565A/en
Publication of CN106474565A publication Critical patent/CN106474565A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23Carbohydrates
    • A61L2300/232Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/426Immunomodulating agents, i.e. cytokines, interleukins, interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明提供一种柞蚕丝素蛋白复合麦芽糊精的活性支架材料的制备方法,该复合支架材料以柞蚕丝素蛋白和麦芽糊精为主要原材料。柞蚕丝素蛋白能够促进成纤维细胞粘附;麦芽糊精具有材料改性剂、致孔剂、细胞营养剂、中性粒细胞趋化剂的作用;该材料的制备工艺中利用相分离‑超声沥滤致孔技术来调节材料的孔径分布和孔隙率,有利于灵活调节材料的力学性能和降解性能,实现支架降解速率与细胞生长速率相匹配;本发明支架材料制备工艺简单,生产周期短,具有较高的临床应用价值,尤其适用于人工皮肤的制备。The invention provides a method for preparing an active support material of tussah silk fibroin protein compounded with maltodextrin. The composite support material uses tussah silk fibroin protein and maltodextrin as main raw materials. Tussah silk fibroin can promote the adhesion of fibroblasts; maltodextrin has the functions of material modifier, porogen, cell nutrient, and neutrophil chemoattractant; the preparation process of the material uses phase separation-ultrasound The leaching pore-forming technology is used to adjust the pore size distribution and porosity of the material, which is beneficial to flexibly adjust the mechanical properties and degradation properties of the material, and realize the matching of the degradation rate of the scaffold with the cell growth rate; the preparation process of the scaffold material of the present invention is simple, and the production cycle is short. It has high clinical application value, and is especially suitable for the preparation of artificial skin.

Description

一种柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法A preparation method of tussah silk fibroin protein compound maltodextrin active scaffold material

技术领域technical field

本发明涉及组织工程支架材料领域,特别是一种柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法。The invention relates to the field of tissue engineering scaffold materials, in particular to a method for preparing an active scaffold material compounded with tussah silk fibroin and maltodextrin.

背景技术Background technique

组织工程是将可降解生物材料制成特定形状和孔径的支架,在生长因子的作用下,结合特定组织来源的活细胞,经体外培养后预先构建一个有生物活性的种植体,然后植入机体,修复或替代缺损组织或器官,最终形成相应的组织或器官并行使相应的工程。因此,组织工程的核心是活细胞和可供细胞进行生命活动的支架材料,以及它们之间的相互总用。支架材料是组织工程化组织的最基本构架,为细胞提供了获取营养、气体交换、排泄废物和生长代谢的场所,也是形成新的具有形态和功能的组织、器官的物质基础,与传统的二维结构(如细胞培养)有着本质的区别。支架材料的产业化是组织工程产业化的前提条件。Tissue engineering is to make degradable biomaterials into scaffolds of specific shape and pore size, under the action of growth factors, combined with living cells from specific tissue sources, pre-build a biologically active implant after in vitro culture, and then implant it into the body , to repair or replace defective tissues or organs, and finally form corresponding tissues or organs and perform corresponding engineering. Therefore, the core of tissue engineering is living cells and scaffolding materials for cells to carry out life activities, as well as their mutual use. Scaffold material is the most basic structure of tissue engineered tissue. It provides cells with a place to obtain nutrients, gas exchange, excrete waste and grow metabolism. It is also the material basis for the formation of new tissues and organs with shape and function. Dimensional structures such as cell cultures are fundamentally different. The industrialization of scaffold materials is a prerequisite for the industrialization of tissue engineering.

组织工程对生物材料的要求越来越高:(1)生物安全性好,对人体无毒无致敏性和无致癌性。(2)生物相容性良好,对人体、组织、血液和免疫系统无不良反应。(3)应具有良好的细胞粘附能力,能尽可能模拟适合细胞生长、增生、分化的生理环境。(4)必须可生物降解,降解产物应无毒,能被机体代谢或清除,降解时间应与愈合过程和再生过程相匹配,有适于操作的力学特性,降解后的力学特性改变应与愈合或再生进程匹配。(5)应有合适的渗透性和预期的可加工性,可按组织、器官的形成任意塑形,有特定的三维几何形状,有一定的孔径和相互连接的三维结构。(6)支架要有一定的柔韧性,可与机体有机的紧密结合在一起。Tissue engineering has higher and higher requirements for biological materials: (1) Good biological safety, non-toxic, non-allergenic and non-carcinogenic to the human body. (2) Good biocompatibility, no adverse reaction to human body, tissue, blood and immune system. (3) It should have good cell adhesion ability and be able to simulate the physiological environment suitable for cell growth, proliferation and differentiation as much as possible. (4) It must be biodegradable. The degradation products should be non-toxic and able to be metabolized or eliminated by the body. The degradation time should match the healing process and regeneration process. It should have mechanical properties suitable for operation. The change of mechanical properties after degradation should be consistent with the healing process. or regeneration process match. (5) It should have suitable permeability and expected processability, can be shaped arbitrarily according to the formation of tissues and organs, have a specific three-dimensional geometric shape, have a certain pore size and an interconnected three-dimensional structure. (6) The bracket must have certain flexibility and can be organically and closely combined with the body.

组织工程皮肤是治疗皮肤创伤和缺损的医疗方法之一。其材料来源广泛,临床使用效果良好。材料选择上有纯天然支架材料、合成支架材料,也有两者复合的支架材料。但总体来说,更占优势和主导地位的仍然是纯天然支架材料。Tissue-engineered skin is one of the medical methods for treating skin wounds and defects. Its materials come from a wide range of sources, and the clinical application effect is good. There are pure natural scaffold materials, synthetic scaffold materials, and composite scaffold materials for the material selection. But in general, pure natural scaffold materials are still more dominant and dominant.

蚕分为家蚕(桑蚕)和野蚕(柞蚕、天蚕、蓖麻蚕等)两类,迄今被工业化利用的只有家蚕茧和柞蚕茧两种,在绝大部分的丝素蛋白材料的研究或报道中,所用原料都是家蚕丝。Silkworms are divided into two types: domestic silkworm (mulberry silkworm) and wild silkworm (tussah silkworm, celestial silkworm, castor silkworm, etc.). So far, only silkworm cocoons and tussah silkworm cocoons have been industrially utilized. In most researches or reports on silk fibroin materials Among them, the raw materials used are silkworm silk.

柞蚕丝是由18种氨基酸组成,但近年来的研究表明:柞蚕丝苏蛋白中含有精氨酸-甘氨酸-天门冬氨酸(RGD)三肽序列,RGD序列作为细胞整合素受体与细胞外配体相结合的识别位点,街道细胞与细胞外基质以及细胞之间的相互作用,能够促进支架对细胞的粘附,使得细胞在柞蚕丝素膜上的附着率和增值率远优于桑蚕丝素膜上的附着率和增值率,被视为新型的可用于人体的生物医学材料。由于柞蚕丝素蛋白的一级结构中含有较多的细胞特异性粘附序列RGD,而家蚕中不含有RGD序列,因此柞蚕丝素蛋白基组织工程支架材料的生物学性能可能比家蚕丝素蛋白更好。Tussah silk is composed of 18 kinds of amino acids, but recent studies have shown that tussah silk threonin contains arginine-glycine-aspartic acid (RGD) tripeptide sequence, RGD sequence acts as a cell integrin receptor and extracellular The recognition site combined with the ligand, the interaction between the street cells and the extracellular matrix and the cells can promote the adhesion of the scaffold to the cells, so that the adhesion rate and value-added rate of the cells on the tussah silk film are much better than those of the mulberry The adhesion rate and value-added rate on the silk fibroin film are regarded as a new type of biomedical material that can be used for the human body. Because the primary structure of tussah silk fibroin contains more cell-specific adhesion sequences RGD, but the silkworm does not contain RGD sequences, the biological performance of tussah silk fibroin-based tissue engineering scaffold materials may be better than that of silkworm silk fibroin. better.

公开号为CN101274109A的专利文献公开一种发泡法制备柞蚕丝素蛋白-高聚物多孔互传网格状支架材料的方法,但该方法由于使用了合成高聚物,从而导致支架在人体中的降解周期难以控制和调节,不利用临床广泛应用。合成聚合物在生物学上呈惰性,有更大的可预测特性,批间的一致性,特定用途上独特的先进性,使得这些植入物通常在患者与患者之间,部位与部位之间的差异比酶解性聚合物植入物更小,但存在疏水性和细胞粘附性差等缺陷,掺和有生物活性的某些生物信号链到合成聚合物形成杂合材料可在一定程度上改善这些缺陷。但合成聚合物材料的物理、化学、生物学和生物力学性质会随时间而改变,产生的降解产物与原材料的组织相容水平也有差异,因此,合成聚合物的生物相容性也需要时间的检验。The patent document with the publication number CN101274109A discloses a method for preparing tussah silk fibroin-high polymer porous intertransfer grid support material by foaming method, but the method uses synthetic high polymer, which leads to the failure of the support in the human body. The degradation cycle is difficult to control and adjust, and it is not widely used in clinical practice. Synthetic polymers are biologically inert, have greater predictable properties, batch-to-batch consistency, and are uniquely advanced for specific uses, making these implants often patient-to-patient and site-to-site The difference is smaller than that of enzymatic polymer implants, but there are defects such as hydrophobicity and poor cell adhesion, and some biological signal chains with biological activity are mixed with synthetic polymers to form hybrid materials. improve these deficiencies. However, the physical, chemical, biological and biomechanical properties of synthetic polymer materials will change over time, and the degradation products produced will also have different levels of tissue compatibility with raw materials. Therefore, the biocompatibility of synthetic polymers also needs time. test.

公开号为100551449A的专利文献公开了一种柞蚕丝素蛋白生物医学材料的制备方法,该发明利用柞蚕丝素蛋白溶液通过静电纺丝法制备成三维无纺网状结构材料,虽然支架的通透性利于细胞的生长,但由于纤维状的丝素蛋白的取向度和结晶度一般偏高,导致体内降解周期可能较长,不利于应用于降解周期较短的组织工程皮肤支架。并且该方法使用静电纺丝法,对纺丝液和设备工艺条件要求较高,不利于灵活调节产品的性能。The patent document with publication number 100551449A discloses a preparation method of tussah silk fibroin biomedical material. The invention utilizes tussah silk fibroin protein solution to prepare a three-dimensional non-woven mesh structure material by electrospinning. However, due to the generally high degree of orientation and crystallinity of fibrous silk fibroin, the degradation cycle in vivo may be longer, which is not conducive to the application of tissue engineering skin scaffolds with a shorter degradation cycle. Moreover, this method uses the electrospinning method, which has high requirements on the spinning solution and equipment process conditions, which is not conducive to flexible adjustment of product performance.

对于皮肤支架来言,要充分考虑所用材料的特性。支架材料显著不同于一般工程材料,因其具有新陈代谢功能,皮肤替代物的临床试验已证明,最理想的支架材料应当是与人体皮肤结构和组成成分一致的有生理活性的蛋白质复合材料,以便更好地适应皮肤复杂的生理要求。For skin scaffolds, the characteristics of the materials used should be fully considered. Scaffold materials are significantly different from general engineering materials, because of their metabolic function, clinical trials of skin substitutes have proved that the most ideal scaffold material should be a physiologically active protein composite material consistent with the structure and composition of human skin, so as to better Well adapted to the complex physiological requirements of the skin.

麦芽糊精是一种低分子量的淀粉衍生物,经常用于食品行业和药用辅料中,其具有良好的保湿性、营养价值和促进免疫细胞趋化的作用,可以促进细胞与材料间的相容和伤口的免疫调节(参见专利文献CN104027346A),利于细胞生长和伤口愈合。将麦芽糊精与柞蚕丝素蛋白复合在一起,不仅可以促进细胞的粘附和创伤的康复,而且制备过程中组分麦芽糊精起到了致孔剂的作用,通过超声沥滤溶出致孔技术可调节组分含量、孔隙率和柞蚕丝素蛋白结晶度,使复合支架的性能调节简单、灵活。Maltodextrin is a low-molecular-weight starch derivative, which is often used in the food industry and pharmaceutical excipients. It has good moisture retention, nutritional value, and the effect of promoting immune cell chemotaxis, and can promote the interaction between cells and materials. Compatibility and wound immune regulation (see patent document CN104027346A), conducive to cell growth and wound healing. Combining maltodextrin and tussah silk fibroin can not only promote cell adhesion and wound healing, but also the component maltodextrin in the preparation process acts as a porogen. The component content, porosity and crystallinity of tussah silk fibroin can be adjusted, so that the performance adjustment of the composite scaffold is simple and flexible.

在公告号为103223192A的专利文献中,介绍了一种桑蚕丝素蛋白与环糊精通过共混后进行冷冻干燥的方法制备了一种用于骨组织工程的复合材料,然该材料并未证明环糊精具有免疫趋化活性。In the patent document with the announcement number 103223192A, a method for preparing a composite material for bone tissue engineering by blending silk fibroin and cyclodextrin and then freeze-drying is introduced, but the material has not been proved Cyclodextrins have immunochemotactic activity.

制备组织工程多孔材料的方法很多,有冷冻干燥法、致孔剂法(盐析法、沥滤法)、发泡法、静电纺丝法、相分离法等。但是,这些致孔方法都是一次致孔,灵活性差;而且,目前所报道的致孔剂法中所制备成品中不含有致孔剂,且往往不可环境降解,增加环保负担。如:公开号为CN105457096A的专利文献公开了一种生物相容性好、可降解的柞蚕丝素蛋白组织工程支架材料的制备方法,该发明介绍了冷冻干燥法、致孔剂法和静电纺丝法三种制备方法,但都是一次致孔,灵活性差,且其与丝素蛋白共混的可降解高聚物以合成聚合物居多,不仅无营养和促进免疫活性,而且降解周期的可调控性很难满足临床需求。因此,提供一种具有降解性且易于调控的用于人工皮肤的复合支架材料已成为本领域亟待解决的技术难题。There are many methods for preparing porous materials for tissue engineering, including freeze-drying, porogen (salting out, leaching), foaming, electrospinning, and phase separation. However, these porogenic methods are all one-time porogenic and have poor flexibility; moreover, the finished products prepared by the porogen method reported so far do not contain porogen, and are often not environmentally degradable, which increases the burden on environmental protection. For example: the patent document with the publication number CN105457096A discloses a preparation method of a biocompatible and degradable tussah fibroin protein tissue engineering scaffold material. The invention introduces the freeze-drying method, porogen method and electrospinning There are three preparation methods, but they are all one-time pore-forming, poor flexibility, and most of the degradable polymers blended with silk fibroin are synthetic polymers, which are not only non-nutritional and immune-promoting, but also have an adjustable degradation cycle. Sex is difficult to meet clinical needs. Therefore, providing a degradable and easy-to-regulate composite scaffold material for artificial skin has become a technical problem to be solved urgently in this field.

发明内容Contents of the invention

针对上述问题,本发明提供一种柞蚕丝素蛋白降解性能易于调控的用于组织工程皮肤支架的活性多孔复合材料及其相分离成型、致孔和超声沥滤二次致孔相结合的制备方法,本发明是这样实现的:In view of the above problems, the present invention provides an active porous composite material for tissue engineering skin scaffolds whose degradation performance of tussah silk fibroin protein can be easily adjusted and its preparation method combining phase separation molding, pore formation and secondary pore formation by ultrasonic leaching , the present invention is realized like this:

一种柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法,其特征在于,具体步骤如下:A preparation method of tussah silk fibroin protein compound maltodextrin active scaffold material, characterized in that, the specific steps are as follows:

(a)配制复合制备液:(a) Prepare compound preparation solution:

将脱胶后的柞蚕茧壳溶于氯化钙和甲酸的复合水溶液中,经过去离子水透析后,浓缩质量浓度为8-10%的柞蚕丝素蛋白水溶液,然后在溶液中再加入麦芽糊精,室温搅拌溶解后获得复合制备液;Dissolve the degummed tussah silkworm cocoon shell in the composite aqueous solution of calcium chloride and formic acid, after dialysis with deionized water, concentrate the tussah silk fibroin protein aqueous solution with a mass concentration of 8-10%, and then add maltodextrin into the solution , after stirring and dissolving at room temperature, the composite preparation solution is obtained;

其中,复合制备液中柞蚕丝素蛋白与麦芽糊精的质量比为5:1-4;Wherein, the mass ratio of tussah silk fibroin and maltodextrin in the composite preparation liquid is 5:1-4;

(b)相分离成型致孔:(b) Phase separation forming porosity:

将复合制备液浸入相变成型剂中浸没4-8h,使复合制备液固化成型,然后置于40℃的真空干燥箱中进行真空干燥,获得多孔状的支架材料;Immersing the composite preparation liquid in the phase change forming agent for 4-8 hours to solidify the composite preparation liquid and then place it in a vacuum drying oven at 40°C for vacuum drying to obtain a porous scaffold material;

所述相变成型剂为乙醇、丙酮、丙醇中的一种;The phase change forming agent is one of ethanol, acetone, propanol;

(c)超声沥滤二次致孔:(c) Secondary pore formation by ultrasonic leaching:

将多孔状的支架材料浸没于体积浓度20-50%的乙醇水溶液中超声浸泡10-60s,使部分麦芽糊精溶出,实现多孔复合支架的第二次成孔,并降低材料的结晶度,然后将材料置于40℃的真空干燥箱中进行真空干燥,即获得所述柞蚕丝素蛋白复合麦芽糊精活性支架材料。Submerge the porous scaffold material in an ethanol aqueous solution with a volume concentration of 20-50% and ultrasonically soak for 10-60s to dissolve part of the maltodextrin, realize the second pore forming of the porous composite scaffold, and reduce the crystallinity of the material, and then The material is placed in a vacuum drying oven at 40° C. for vacuum drying to obtain the tussah silk fibroin protein-complexed maltodextrin active scaffold material.

(d)保存:将所述柞蚕丝素蛋白复合麦芽糊精活性支架材料置于真空封口袋密封,置于0~8℃的冰箱中保存,并降低材料的结晶度,(d) Preservation: put the tussah silk fibroin protein compound maltodextrin active scaffold material into a vacuum sealing bag and seal it, store it in a refrigerator at 0-8°C, and reduce the crystallinity of the material,

进一步,本发明所述柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法中,步骤(a)中柞蚕丝素蛋白水溶液中的柞蚕丝素蛋白平均分子量为20-200KDa。Furthermore, in the preparation method of tussah silk fibroin protein composite maltodextrin active scaffold material of the present invention, the average molecular weight of tussah silk fibroin protein in the tussah silk fibroin protein aqueous solution in step (a) is 20-200KDa.

进一步,本发明所述柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法中,步骤(a)中麦芽糊精的DE值为10-20。Furthermore, in the preparation method of tussah silk fibroin protein composite maltodextrin active scaffold material of the present invention, the DE value of maltodextrin in step (a) is 10-20.

进一步,本发明所述柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法中,步骤(a)所述复合制备液中柞蚕丝素蛋白与麦芽糊精的质量比为11-171:9。Furthermore, in the preparation method of tussah fibroin protein composite maltodextrin active scaffold material of the present invention, the mass ratio of tussah silk fibroin protein to maltodextrin in the composite preparation solution in step (a) is 11-171:9.

进一步,本发明所述柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法中,步骤(a)所述麦芽糊精为药用麦芽糊精。Further, in the preparation method of tussah silk protein composite maltodextrin active scaffold material of the present invention, the maltodextrin in step (a) is medicinal maltodextrin.

进一步,本发明所述柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法中,步骤(c)超声功率为25-40KHz。。Further, in the preparation method of tussah silk fibroin protein compound maltodextrin active scaffold material of the present invention, the ultrasonic power in step (c) is 25-40KHz. .

进一步,本发明所述柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法中,步骤(c)获得的柞蚕丝素蛋白基活性复合支架材料的孔隙率为孔隙率为75-95%。Furthermore, in the preparation method of the tussah fibroin protein-based active composite scaffold material of the present invention, the porosity of the tussah silk fibroin protein-based active composite scaffold material obtained in step (c) is 75-95%.

进一步,本发明所述柞蚕丝素蛋白复合麦芽糊精活性支架材料的制备方法中,步骤(c)获得的柞蚕丝素蛋白基活性复合支架材料的孔径为10-500mm。Furthermore, in the preparation method of the tussah fibroin protein-based active composite scaffold material of the present invention, the pore diameter of the tussah silk fibroin protein-based active composite scaffold material obtained in step (c) is 10-500 mm.

与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:

1、本发明在柞蚕丝素蛋白基支架材料中复合有低分子量的麦芽糊精。麦芽糊精是一种多糖类淀粉衍生物,也是一种中性粒细胞趋化剂。通过控制其用量和致孔溶出量,既可以调节复合支架的组成和性能,又能够起到致孔剂的作用,还具有一定的细胞营养作用和免疫调节作用。1. In the present invention, low molecular weight maltodextrin is compounded in the tussah silk fibroin-based scaffolding material. Maltodextrin is a polysaccharide starch derivative and a neutrophil chemoattractant. By controlling its dosage and pore-forming dissolution rate, it can not only adjust the composition and performance of the composite scaffold, but also act as a porogen, and also have certain cell nutrition and immune regulation effects.

2、本发明步骤(a)复合制备液在有机凝固浴中相分离成型为多孔状材料后,使用了超声波沥滤的二次致孔技术。该方法有利于提高支架材料的孔隙率和通透性;同时,该方法可通过超声沥滤时间长短来调节半成品复合支架中柞蚕丝素蛋白的结晶度,既有利于支架材料的降解周期与伤口愈合周期相匹配,又可灵活调节支架性能,缩短了传统制备方法从溶液配制到成品制造的生产周期。2. After the composite preparation solution in step (a) of the present invention is phase-separated into a porous material in an organic coagulation bath, the secondary pore-forming technology of ultrasonic leaching is used. This method is beneficial to improve the porosity and permeability of the scaffold material; at the same time, this method can adjust the crystallinity of tussah silk fibroin in the semi-finished composite scaffold through the length of ultrasonic leaching time, which is beneficial to the degradation cycle of the scaffold material and wound healing. The healing cycle is matched, and the performance of the scaffold can be flexibly adjusted, which shortens the production cycle of the traditional preparation method from solution preparation to finished product manufacturing.

3、本发明的复合支架材料的组分均来源于天然大分子,均可以体内降解吸收,生物相容性好。且作为组分之一的致孔剂麦芽糊精是淀粉衍生物,易于环境降解,无环保负担。3. The components of the composite scaffold material of the present invention are all derived from natural macromolecules, can be degraded and absorbed in vivo, and have good biocompatibility. And the porogen maltodextrin as one of the components is a starch derivative, which is easy to be degraded by the environment and has no environmental burden.

4、本发明的制备工艺较简单、环保、低毒、低能耗、生产周期短,有利于进行工业化批量生产和应急生产。4. The preparation process of the present invention is relatively simple, environmentally friendly, low in toxicity, low in energy consumption, and short in production cycle, which is conducive to industrialized mass production and emergency production.

具体实施方式detailed description

以下通过实施例对本发明技术思想做进一步说明,实施例中所涉及的试剂和材料,除非特别说明,均是由商业途径购买获得。The technical idea of the present invention will be further described through the following examples. The reagents and materials involved in the examples are purchased from commercial channels unless otherwise specified.

实施例中使用的药用麦芽糊精购自山东西王药业有限公司,DE值为10-20。The medicinal maltodextrin used in the examples was purchased from Shanxi Xiwang Pharmaceutical Co., Ltd., with a DE value of 10-20.

实施例1Example 1

1、配制复合制备液:1. Prepare compound preparation solution:

将柞蚕干茧壳经过0.02M的碳酸钠煮沸脱除丝胶,然后将脱胶茧壳溶解于摩尔比依次为1:3:15的氯化钙、甲酸、水的三元混合溶液中,在截留分子量为12000的透析膜中经去离子水透析后,过滤去除不溶性杂质,经浓缩得到质量比为8%的柞蚕丝素蛋白水溶液;然后,将药用麦芽糊精粉溶解于上述溶液中,搅拌均匀获得复合制备液。Boil the dried tussah cocoon shells in 0.02M sodium carbonate to remove sericin, then dissolve the degummed cocoon shells in a ternary mixed solution of calcium chloride, formic acid, and water with a molar ratio of 1:3:15, After dialysis with deionized water in a dialysis membrane with a molecular weight of 12000, filter to remove insoluble impurities, and concentrate to obtain an aqueous solution of tussah silk fibroin protein with a mass ratio of 8%; then, dissolve medicinal maltodextrin powder in the above solution, and stir Obtain the composite preparation solution evenly.

复合制备液中柞蚕丝素蛋白与药用麦芽糊精的质量比为11:9。The mass ratio of tussah silk fibroin protein to medicinal maltodextrin in the compound preparation liquid is 11:9.

2、相分离成型、致孔:2. Phase separation forming and porosity:

将10mL复合制备液倒入Φ35mm×12mm(直径x高度)模具中,然后置于乙醇中成型、致孔6h,然后置于40℃真空干燥箱中干燥,即获得多孔状的支架材料。Pour 10mL of the composite preparation solution into a Φ35mm×12mm (diameter×height) mold, then place it in ethanol for molding, cause pores for 6 hours, and then dry it in a vacuum oven at 40°C to obtain a porous scaffold material.

3、超声二次沥滤致孔:3. Ultrasonic secondary leaching causes pores:

将多孔状的支架材料浸入体积浓度为50%的乙醇水溶液中,超声60s,频率25kHz,以溶解部分麦芽糊精,提高孔隙率,降低结晶度;然后置于40℃真空干燥箱中干燥,即获得所述柞蚕丝素蛋白基活性复合支架材料。Immerse the porous scaffold material in an aqueous ethanol solution with a volume concentration of 50%, and ultrasonicate for 60s at a frequency of 25kHz to dissolve part of the maltodextrin, increase the porosity, and reduce the crystallinity; then dry it in a vacuum oven at 40°C. The tussah silk fibroin-based active composite scaffold material is obtained.

4、将获得的即获得所述柞蚕丝素蛋白基活性复合支架材料,密封于真空袋中,冰箱低温保存。4. Seal the obtained tussah fibroin protein-based active composite scaffold material in a vacuum bag and store it in a refrigerator at low temperature.

实施例2Example 2

1、配制复合复合制备液:1. Prepare compound compound preparation solution:

将柞蚕干茧壳经过0.02M的碳酸钠煮沸脱除丝胶,然后将脱胶茧壳溶解于摩尔比为1:2:12的氯化钙、甲酸、水的三元混合溶液中,在截留分子量为12000的透析膜中经去离子水透析后,过滤去除不溶性杂质,经浓缩得到质量分数为8%的柞蚕丝素蛋白水溶液。然后,将麦芽糊精粉溶解于上述溶液中,制备成复合制备液。Boil the dried cocoon shells of tussah silkworms with 0.02M sodium carbonate to remove sericin, and then dissolve the degummed cocoon shells in a ternary mixed solution of calcium chloride, formic acid, and water with a molar ratio of 1:2:12. After dialysis with deionized water in a 12000 dialysis membrane, filter to remove insoluble impurities, and concentrate to obtain an aqueous solution of tussah silk fibroin protein with a mass fraction of 8%. Then, the maltodextrin powder is dissolved in the above solution to prepare a composite preparation solution.

复合制备液中柞蚕丝素蛋白与药用麦芽糊精的质量比为100:9。The mass ratio of tussah silk fibroin protein to medicinal maltodextrin in the compound preparation liquid is 100:9.

2、相分离成型、致孔:2. Phase separation forming and porosity:

将10mL复合制备液倒入Φ35mm×12mm模具中,然后置入丙酮中成型、致孔4h,40℃真空干燥。Pour 10mL of composite preparation solution into a Φ35mm×12mm mold, then place it in acetone for molding, cause holes for 4h, and vacuum dry at 40°C.

3、超声二次沥滤致孔:3. Ultrasonic secondary leaching causes pores:

将40℃真空干燥后获得的多孔状的支架材料,浸入体积浓度为30%的乙醇水溶液中,超声30s,超声频率28kHz,溶解出部分麦芽糊精,然后将材料置于40℃真空干燥箱中干燥,即获得所述柞蚕丝素蛋白基活性复合支架材料。The porous scaffold material obtained after vacuum drying at 40°C was immersed in an ethanol aqueous solution with a volume concentration of 30%, ultrasonicated for 30s at a frequency of 28kHz to dissolve part of the maltodextrin, and then the material was placed in a vacuum drying oven at 40°C After drying, the tussah silk fibroin-based active composite scaffold material is obtained.

实施例3Example 3

1、配制复合复合制备液:1. Prepare compound compound preparation solution:

将柞蚕干茧壳经过0.02M的碳酸钠煮沸脱除丝胶,然后将脱胶茧壳溶解于摩尔比为1:3:12的氯化钙、甲酸、水的三元混合溶液中,在截留分子量为3500的透析膜中经去离子水透析后,过滤去除不溶性杂质,经浓缩得到质量比为10%的柞蚕丝素蛋白水溶液;然后,将麦芽糊精粉溶解于上述溶液中,则制备成复合制备液。Boil the dried tussah silkworm cocoons with 0.02M sodium carbonate to remove sericin, and then dissolve the degummed cocoon shells in a ternary mixed solution of calcium chloride, formic acid, and water with a molar ratio of 1:3:12. After dialysis with deionized water in a 3500 dialysis membrane, filter to remove insoluble impurities, and concentrate to obtain an aqueous solution of tussah silk fibroin protein with a mass ratio of 10%; then, dissolve maltodextrin powder in the above solution to prepare a compound Preparation solution.

复合制备液中柞蚕丝素蛋白与药用麦芽糊精的质量比为171:9。The mass ratio of tussah silk fibroin to medicinal maltodextrin in the compound preparation liquid is 171:9.

2、相分离成型、致孔:2. Phase separation forming and porosity:

将5mL复合制备液倒入Φ35mm×12mm模具中,然后置入丙醇中成型、致孔8h,然后40℃真空干燥后获得多孔状的支架材料。Pour 5mL of the composite preparation solution into a Φ35mm×12mm mold, then place it in propanol for molding, cause pores for 8 hours, and then vacuum-dry at 40°C to obtain a porous scaffold material.

3、超声二次沥滤致孔:3. Ultrasonic secondary leaching causes pores:

将获得的多孔状的支架材料浸入体积浓度为20%的乙醇水溶液中,超声10s,频率40kHz,溶解出部分麦芽糊精,然后置于40℃真空干燥,即获得所述柞蚕丝素蛋白基活性复合支架材料。Immerse the obtained porous scaffold material in an aqueous ethanol solution with a volume concentration of 20%, ultrasonicate for 10s at a frequency of 40kHz to dissolve part of the maltodextrin, and then place it at 40°C for vacuum drying to obtain the tussah silk fibroin-based activity Composite scaffold material.

具体操作过程中,复合制备液中柞蚕丝素蛋白与麦芽糊精的质量比也可以在11-171:9的范围内选择,均可实现本发明之目的。In the specific operation process, the mass ratio of tussah silk fibroin protein to maltodextrin in the compound preparation liquid can also be selected within the range of 11-171:9, both of which can achieve the purpose of the present invention.

Claims (9)

1. a kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material it is characterised in that concrete steps As follows:
(a)Prepare compound preparation solution:
By tussah silk peptide dried cocoon shell after the sodium carbonate liquor of 0.02M boils 30min degumming, it is dissolved in the compound of calcium chloride and formic acid In aqueous solution, after deionized water dialysis, it is concentrated to give the tussah silk fibroin aqueous solution that mass concentration is 8-10%, then Maltodextrin is added in above-mentioned solution, obtains the compound preparation solution of tussah silk fibroin and maltodextrin;
(b)Separated molding pore:
Compound preparation solution is immersed in phase transformation forming agent, submergence 4-8h, it is subsequently placed in 40 DEG C of vacuum drying, obtain cavernous Frame material;
Described phase transformation forming agent is one of ethanol, acetone, propanol;
(c)The secondary pore of ultrasonic leaching:
Cavernous timbering material is immersed in ultrasonic immersion 10-60s in the ethanol water that volumetric concentration is 20-50%, then It is placed in 40 DEG C of vacuum drying, that is, obtain described tussah silk fibroin and be combined maltodextrin active scaffold material.
2. tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material, its feature according to claim 1 It is, described step(a)Tussah silk fibroin mean molecule quantity in middle tussah silk fibroin aqueous solution is 20-200KDa.
3. tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material, its feature according to claim 2 It is, step(a)The DE value of middle maltodextrin is 10-20.
4. it is combined the preparation method of maltodextrin active scaffold material according to the described tussah silk fibroin of one of claim 1-3, It is characterized in that, in the compound aqueous solution of described calcium chloride and formic acid, the mol ratio of calcium chloride, formic acid and water is followed successively by 1:2-3: 12-15.
5. it is combined the preparation method of maltodextrin active scaffold material according to the described tussah silk fibroin of one of claim 1-3, It is characterized in that, step(a)In described compound preparation solution, tussah silk fibroin is 11-171 with the mass ratio of maltodextrin:9.
6. it is combined the preparation method of maltodextrin active scaffold material according to the described tussah silk fibroin of one of claim 1-3, It is characterized in that, step(a)Described maltodextrin is medicinal maltodextrin.
7. tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material, its feature according to claim 6 It is, step(c)Ultrasonic power is 25-40KHz.
8. it is combined the preparation method of maltodextrin active scaffold material according to the described tussah silk fibroin of one of claim 1-3, It is characterized in that, step(c)The porosity of the tussah silk fibroin base activity compound support frame material obtaining is 75-95%.
9. tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material, its feature according to claim 8 It is, step(c)The aperture of the tussah silk fibroin base activity compound support frame material obtaining is 10-500mm.
CN201611126018.1A 2016-12-09 2016-12-09 A kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material Withdrawn CN106474565A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611126018.1A CN106474565A (en) 2016-12-09 2016-12-09 A kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611126018.1A CN106474565A (en) 2016-12-09 2016-12-09 A kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material

Publications (1)

Publication Number Publication Date
CN106474565A true CN106474565A (en) 2017-03-08

Family

ID=58276016

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611126018.1A Withdrawn CN106474565A (en) 2016-12-09 2016-12-09 A kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material

Country Status (1)

Country Link
CN (1) CN106474565A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108070106A (en) * 2017-11-22 2018-05-25 玖久丝绸股份有限公司 A kind of preparation method of fibroin albumen grafting maltodextrin porous material

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070065481A1 (en) * 2005-09-21 2007-03-22 Chudzik Stephen J Coatings including natural biodegradable polysaccharides and uses thereof
CN103223192A (en) * 2013-04-03 2013-07-31 浙江大学 Preparation method of composite material of silk fibroin and cyclodextrin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070065481A1 (en) * 2005-09-21 2007-03-22 Chudzik Stephen J Coatings including natural biodegradable polysaccharides and uses thereof
CN103223192A (en) * 2013-04-03 2013-07-31 浙江大学 Preparation method of composite material of silk fibroin and cyclodextrin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108070106A (en) * 2017-11-22 2018-05-25 玖久丝绸股份有限公司 A kind of preparation method of fibroin albumen grafting maltodextrin porous material
CN108070106B (en) * 2017-11-22 2020-06-30 玖久丝绸股份有限公司 A kind of preparation method of silk fibroin grafted maltodextrin porous material

Similar Documents

Publication Publication Date Title
CN104004221B (en) Method for preparing polycaprolactone-keratin composite porous scaffolds
CN102430155B (en) Cellular silk fibroin porous scaffold, and preparation method thereof
CN101897994A (en) A biocomposite scaffold for repairing bone defects and its preparation method
CN106075582A (en) A kind of engineering blood vessel support and construction method thereof
CN104984393B (en) A kind of bone tissue engineering stent material and preparation method thereof
CN101596327A (en) A kind of preparation method of three-dimensional silk fibroin porous scaffold material
CN101773684A (en) Preparation method of fibroin/hydroxyapatite porous scaffold
CN102552985B (en) Silk fibroin/calcium phosphate bone cement-based porous composite material and preparation method thereof
CN103263308B (en) Many micropores degradable collagen-chitin nerve trachea and preparation method thereof
CN109851819A (en) A kind of Injectable silk fibroin porous aquagel and preparation method thereof
CN100382772C (en) Preparation method of medical nerve graft containing silk fibroin
CN107789674B (en) Preparation method of composite biological membrane material with porous microsphere structure, product and application thereof
CN101143941A (en) Cellulose/soybean protein composite sponge and preparation method thereof
CN103007358B (en) Cartilage tissue engineering fiber scaffold material and preparation method thereof
CN102580145B (en) Method for preparing phosphomycin calcium/hexagonal mesoporous silicon/poly glycolide-co-lactide (PLGA) bone tissue stent
CN104017230A (en) Preparation method of polyurethane-keratin composite film
CN116942908B (en) Absorbable biological isolation composite membrane material and preparation method thereof
CN110215540B (en) A silk fibroin/polymer-based tubular scaffold with a three-dimensional ordered and disordered double network structure and its preparation and use methods
CN103948963B (en) A kind of tissue engineering bracket and preparation method thereof being applicable to human internal organ and building
CN106474565A (en) A kind of tussah silk fibroin is combined the preparation method of maltodextrin active scaffold material
CN102580162A (en) Method for preparing hydroxyapatite/poly glycolide-co-lactide (PLGA)/chitosan three-dimensional porous stent
CN106902398B (en) Cationized silk fibroin material, preparation method and application thereof
CN103480036A (en) Preparation method for porous nano-composite support material of bone tissue engineering
CN101274109B (en) Method for preparing tussah silk fibroin-high polymer stephanoporate interpenetrating grid shaped bracket material with foaming method
JP2003126125A (en) Artificial blood vessel and method of preparing it

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170308